CHI3L2 and central nervous system cancer: In the study by Liu et al, YKL-39 was shown to be associated with tumor immune infiltration and affect the prognosis of patients with glioma, and high expression of YKL-39 is an independent adverse prognostic factor in glioma patients [20].